How Companies Sneak Chemicals Past FDA Rules Into Foods
Regulators warn of a loophole that allows new chemicals to enter foods and supplements without premarket approval. Th...
2024 highlights the most tax-efficient Dividend Etfs and the factors behind their efficiency, helping you pick better tax-smart options.
24,637 articlesRegulators warn of a loophole that allows new chemicals to enter foods and supplements without premarket approval. Th...
As Apple schedules its July 30 earnings, a growing cohort of investors signals a core, long-horizon bet on cash gener...
Midday action hinges on Alphabet's report and the AI spend cycle. Learn what moves markets, how hyperscalers shape ri...
Oil prices slid more than 5% on Monday as Washington urged allies to join a broader effort to safeguard the Strait of...
If you’re searching for durable growth over the next five years, two well-positioned names belong in many calendars. ...
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Hedge fund titan Ken Griffin challenges the AI hype, insisting the revolution is misunderstood and urging investors t...
AT&T stunned investors with a record quarter, accelerating buybacks and signaling a robust cash flow backdrop. Here’s...
A concise look at the weapons that altered modern warfare and how investors are pricing defense tech in 2026.
A dramatic legal verdict against a tech titan could reshape how investors view AI, crypto, and venture risk. This art...
Discover how to read arbe (arbe) 2025 earnings from the Q4 transcript, uncover management priorities, and turn insigh...
Broadcom and Marvell delivered AI-fueled earnings, but the race to sustain AI momentum hinges on scale, software, and...